Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-041089

Director sold 2,500 shares at $38.56 ($96,400)

  • Director acquired 2,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

GRIFFIN MICHELLE RENEE · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-06-14 Exercise or conversion : show line 1 in the form +2,500 $7.80 $19,500 4,004 D
2021-06-14 Sale : show line 2 in the form −2,500 $38.56 $96,400 1,504 D
Open-market sales · 2,500 sh · avg $38.56 · $96,400

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-06-14 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −2,500 73,500 D
Loading xslF345X03/doc4.xml…